Free Trial
LON:IBT

International Biotechnology (IBT) Share Price, News & Analysis

International Biotechnology logo
GBX 546 +10.00 (+1.87%)
As of 04/17/2025 11:50 AM Eastern

About International Biotechnology Stock (LON:IBT)

Key Stats

Today's Range
540
548
50-Day Range
480
720
52-Week Range
480
736
Volume
52,933 shs
Average Volume
80,897 shs
Market Capitalization
£196.13 million
P/E Ratio
5.21
Dividend Yield
5.31%
Price Target
N/A
Consensus Rating
N/A

Company Overview

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services. While the Company’s portfolio is held as one pool of assets, for operational purposes there is a quoted portfolio and an unquoted portfolio. The portfolio is diversified by geography, industry sub-sector and investment size with no single investment in a company normally accounting for more than 15% of the portfolio at the time of investment. The portfolio is split between large, mid and small-capitalisation companies, primarily quoted on stock exchanges in North America, where the most established and commercial biotech and other life sciences companies and companies operating in related sectors are based, though investments will also be made in Europe, Asia and Australia. Investments may also be made into unquoted companies and into funds not quoted on a stock exchange, including venture capital funds. This may include funds managed by the Investment Manager and/or members of its group. The primary purpose of investment in unquoted funds will be to gain exposure to unquoted companies. The Company may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Forward or derivative transactions are not used by the Company. The Company may borrow from time to time to exploit specific investment opportunities, rather than to apply long-term structural gearing to the Company’s portfolio of investments.

Receive IBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

IBT Stock News Headlines

Trump to unlock 15-figure fortune for America (May 3rd) ?
We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.
See More Headlines

IBT Stock Analysis - Frequently Asked Questions

International Biotechnology's stock was trading at GBX 682 at the beginning of the year. Since then, IBT shares have decreased by 19.9% and is now trading at GBX 546.
View the best growth stocks for 2025 here
.

International Biotechnology (LON:IBT) released its earnings results on Tuesday, November, 5th. The company reported ($9.16) earnings per share for the quarter. International Biotechnology had a net margin of 90.66% and a trailing twelve-month return on equity of 13.67%.

Shares of IBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that International Biotechnology investors own include Vanquis Banking Group (PFG), 1724525 (ADN.L) (ADN), abrdn New India Investment Trust (ANII), The Berkeley Group (BKG), GLI Finance (GLIF), Hurricane Energy (HUR) and Oxford Pharmascience Group (OXP).

Company Calendar

Last Earnings
11/05/2024
Record date for 1/24 Dividend
12/19/2024
Ex-Dividend for 1/24 Dividend
12/19/2024
Dividend Payable
1/24/2025
Today
4/19/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Asset Management
Sub-Industry
N/A
Current Symbol
LON:IBT
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
5.21
Forward P/E Ratio
578.64
P/E Growth
N/A
Net Income
£37.91 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£41.82 million
Cash Flow
GBX 3.51 per share
Price / Cash Flow
155.74
Book Value
GBX 766.24 per share
Price / Book
0.71

Miscellaneous

Free Float
N/A
Market Cap
£196.13 million
Optionable
Not Optionable
Beta
0.21
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (LON:IBT) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners